Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
about
HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cellsHypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cellsHypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor relatedGene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancersHypoxic control of metastasisRole of hypoxia-inducible factors in breast cancer metastasisHypoxamiRs and cancer: from biology to targeted therapyCombination therapy for renal cell cancer: what are possible options?Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomesImplications of Hypoxia in Breast Cancer Metastasis to BoneAngiogenesis and Antiangiogenesis in Triple-Negative Breast cancerDifferential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancerELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinomaDefining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsThe impact of O2 availability on human cancerNecrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.Hypoxia inducible factor 1alpha gene (HIF-1alpha) splice variants: potential prognostic biomarkers in breast cancer.Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.FBP1 expression is associated with basal-like breast carcinomaClinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.Clinical biomarkers for hypoxia targetingHIF-1alpha: a valid therapeutic target for tumor therapyMolecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsHypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma.The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein.Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells.Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.A profile of prognostic and molecular factors in European and Māori breast cancer patients.TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cellsHIF1-alpha expression predicts survival of patients with squamous cell carcinoma of the oral cavityKalkitoxin inhibits angiogenesis, disrupts cellular hypoxic signaling, and blocks mitochondrial electron transport in tumor cellsVEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer.Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenograftsHIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs.Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells.
P2860
Q24338405-B591D517-50DA-4031-B42C-2C259F18080DQ24613508-CB1C4B65-73C6-4EDF-A78F-40A421FA0DBFQ24794814-C07CE59E-536F-4DB4-9AC3-1FBDB57CB5B4Q24806403-D0CFDB18-F789-4704-846B-1D12BF76ED59Q25255387-A9EB21A2-AF8D-4EFA-A153-4FEA8DE0F861Q26749159-D4E76FAD-15FE-4AF4-939F-FE31BE33CFFFQ26860122-A3B1C520-7701-4619-9ECE-55BECC8ED048Q26863298-17131A4E-69CD-4087-9B08-2984CB400AB0Q27011663-C25EAF73-CCE5-4E78-991C-11C680C70269Q27853336-D520BE10-8FC9-4D4B-BE65-7A44C3719B8EQ28077444-DA9CD0F5-A674-46C1-821E-D2CF236E7BBAQ28079013-81177407-8410-4171-8E73-0BAE626BF4BAQ28477182-3A53BE2D-F2C9-4B6D-BD00-ADC1D87AA37CQ28479196-27725865-8604-4994-BE53-6A8CD5A4F292Q29615944-E75EA83E-4B24-42F9-B24C-FC48412E06F2Q29619884-22306BA8-1262-4480-BB40-3C35BA087B06Q33611310-9CBE62E5-447A-429D-A365-3D41B8EFA2ADQ33630831-CFC824F6-7E25-45F6-AC23-E37E29F0996EQ33665254-7179A318-014F-403B-B8F8-60419092F998Q33686009-37E4A646-5BA7-4F91-A21C-6660BC904640Q33706337-866C075A-FF0E-4BB9-95AE-D57C765B5039Q33714638-441E24D7-C65E-4CAC-AF66-DA0915FA347BQ33746822-DDB3DF44-47FB-4A0E-9700-D06D470C42E5Q34023663-6F5C1D19-8067-48CE-A572-28B96D2E053FQ34025482-150046E3-D40E-4421-A325-0F988DA3D4CCQ34099348-00BA310A-C574-4C11-83A2-C999AF563D98Q34123758-8C444EFD-E079-42FC-987C-037B692D5BC2Q34152742-DE93B78C-DD45-4621-8781-C41BC1A96344Q34198351-EC2D36D9-C450-4CC9-82D7-882FE25265E4Q34243710-EFDB6AAB-B1A1-4145-8A52-BA2DE2818130Q34407155-DEB5CB50-9D3F-4DB2-A96F-DF808115B89BQ34428411-D479925F-A3BE-4AA4-A3B8-4253A5C9666EQ34468368-53F4400A-BAA9-4017-B039-3E052C9BC7D3Q34551161-56EE7EB4-EC74-4683-B609-341F05055794Q34622198-B57FB018-0E2B-4E96-8AA2-440BC52822A1Q34628919-328B0E48-A50D-4E25-A618-AE685A0CA125Q34672437-1D0F3AE2-FDE9-4CD0-896B-05FAD0DECEC3Q35051166-90BF209A-8889-4169-A5C1-3618E23D449DQ35058837-72910476-EC9D-4161-B823-2DF89E6B8E67Q35134466-2008EC1A-B48D-41D9-A54B-EF55564271D9
P2860
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Overexpression of hypoxia-indu ...... h node-positive breast cancer.
@ast
Overexpression of hypoxia-indu ...... h node-positive breast cancer.
@en
type
label
Overexpression of hypoxia-indu ...... h node-positive breast cancer.
@ast
Overexpression of hypoxia-indu ...... h node-positive breast cancer.
@en
prefLabel
Overexpression of hypoxia-indu ...... h node-positive breast cancer.
@ast
Overexpression of hypoxia-indu ...... h node-positive breast cancer.
@en
P2093
P921
P1476
Overexpression of hypoxia-indu ...... ph node-positive breast cancer
@en
P2093
Austrian Breast and Colorectal Cancer Study Group
Ernst Kubista
Georg Oberhuber
Hellmut Samonigg
Hubert Hausmaninger
Monika Schindl
Peter Birner
Raimund Jakesz
Werner Kwasny
P304
P407
P577
2002-06-01T00:00:00Z